| 13.06. | INSIDER SELL : Catalent |  |
| 10.06. | Catalent Supports U.S. Launch of Phathom Pharmaceuticals' New Products Following Regula.. | |
| 08.06. | TRANSCRIPT : Catalent, Inc. Presents at 2022 Jefferies Global Healthcare Conference, Jun-0.. | |
| 07.06. | TRANSCRIPT : Catalent, Inc. Presents at William Blair’s 42nd Annual Growth Stock Conf.. | |
| 07.06. | CATALENT : and MigVax Sign Agreement to Develop an Orally Disintegrating Freeze-Dried Tabl.. | |
| 27.05. | Catalent, Inc. to Present at June Investor Conferences | |
| 20.05. | Catalent Invests $175 Million to Expand Manufacturing Capabilities and Capacity at Winc.. | |
| 17.05. | Catalent Launches UpTempo Virtuoso AAV Platform to Reduce Gene Therapy Development Time.. | |
| 11.05. | TRANSCRIPT : Catalent, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11.. | |
| 03.05. | SECTOR UPDATE : Health Care Advance Led Higher by Biotechs | |
| 03.05. | SECTOR UPDATE : Health Care | |
| 03.05. | Catalent Reports Increase in Fiscal Q3 Adjusted Net Income, Revenue; Raises FY2022 Targ.. | |
| 03.05. | CATALENT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS.. | |
| 03.05. | TRANSCRIPT : Catalent, Inc., Q3 2022 Earnings Call, May 03, 2022 | |
| 03.05. | CATALENT : Fiscal Q3 Earnings Snapshot | |
| 03.05. | Catalent, Inc. Reports Third Quarter Fiscal 2022 Results | |
| 03.05. | Earnings Flash (CTLT) CATALENT Posts Q3 Revenue $1.27B, vs. Street Est of $1.22B | |
| 03.05. | Catalent, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Mar.. | |
| 03.05. | Catalent, Inc. Raises Revenue Guidance for the Full Year of 2022 | |
| 03.05. | CATALENT : CTLT FY22 Q3 Earnings Call Presentation | |
| 28.04. | CATALENT : Expands Nasal Drug Development and Manufacturing Capabilities at Morrisville, N.. | |
| 25.04. | CATALENT : Acquires Commercial-Scale Cell Therapy Development and Manufacturing Facility i.. | |
| 25.04. | Catalent, Inc. acquired Commercial-Scale Cell Therapy Development and Manufacturing Fac.. | |
| 25.04. | Catalent, Inc. acquired Cell therapy manufacturing facility in Princeton, New Jersey of.. | |
| 21.04. | CATALENT : to Invest $350 Million in Integrated Biologics Drug Substance and Drug Product .. | |
| 20.04. | Expanding Operations In Biologics | |
| 18.04. | Catalent Adds 4 New Encapsulation Manufacturing Suites at Kansas City Facility | |
| 15.04. | WEEKLY MARKET UPDATE : The market stopped its rise | |
| 15.04. | Catalent, Inc. Announces Third Quarter Fiscal Year 2022 Earnings Conference Webcast | |
| 14.04. | CATALENT : Adds New High-Throughput Encapsulation Manufacturing Suites at Kansas City, Mis.. | |
| 07.04. | Marvel biosciences initiates formulation development with catalent | |
| 06.04. | Marvel Biosciences Corp. Initiates Its Pre-Clinical Oral Formulation Studies for Its Le.. | |
| 06.04. | CATALENT : Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and.. | |
| 06.04. | Catalent, Inc. acquired Biologics development and manufacturing facility of VMIC Ltd. | |
| 23.03. | Catalent, Inc. Provides Earning Guidance for 2022 | |
| 23.03. | TRANSCRIPT : Catalent, Inc. Presents at 2022 KeyBanc Capital Markets Life Sciences and Med.. | |
| 18.03. | Catalent, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum | |
| 17.03. | CATALENT : Appoints Frederic Cedrone as Vice President, Corporate Innovation | |
| 16.03. | CATALENT : Biologics Completes $30 Million Project for Biopharmaceutical Development and D.. | |
| 10.03. | Catalent Publishes Third Annual Corporate Responsibility Report | |
| 03.03. | CATALENT : Expands Temperature-Controlled Clinical Supply Capabilities in Shanghai, China | |
| 01.03. | TFF Pharmaceuticals, Inc. and Catalent Announce Their Collaboration Agreement Focused o.. | |
| 28.02. | Catalent's Dartisla ODT Peptic Ulcer Drug Available in US | |
| 15.02. | CATALENT : Expands Temperature-Controlled Clinical Supply Capabilities in Shanghai, China | |
| 09.02. | INSIDER SELL : Catalent | |
| 07.02. | CATALENT : Recognized as a US and UK Country Certified Top Employer 2022 | |
| 01.02. | Health Care Stocks Back Near Even For Tuesday Trading | |
| 01.02. | Health Care Stocks Losing More Ground This Afternoon | |
| 01.02. | CATALENT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS.. | |
| 01.02. | Catalent, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Dec.. | |
| 01.02. | TRANSCRIPT : Catalent, Inc., Q2 2022 Earnings Call, Feb 01, 2022 | |
| 01.02. | Catalent, Inc. revises Earnings Guidance for the Fiscal Year 2022 | |
| 01.02. | CATALENT : CTLT FY22 Q2 Earnings Call Presentation | |
| 01.02. | Catalent Fiscal Q2 Adjusted EPS, Revenue Rise; Full-Year 2022 Guidance Lifted -- Shares.. | |
| 01.02. | CATALENT : Fiscal Q2 Earnings Snapshot | |
| 01.02. | CATALENT : Reports Second Quarter Fiscal 2022 Results - Form 8-K | |
| 01.02. | CATALENT, INC. : Results of Operations and Financial Condition, Amendments to Articles of .. | |
| 01.02. | Catalent, Inc. Reports Second Quarter Fiscal 2022 Results | |
| 01.02. | Earnings Flash (CTLT) CATALENT Posts Q2 Revenue $1.22B, vs. Street Est of $1.15B | |
| 01.02. | NORTH AMERICAN MORNING BRIEFING : Stocks Futures -2- | |
| 25.01. | CATALENT : Completes $10 Million Expansion of High Potency Micronization Capabilities at U.. | |
| 21.01. | Catalent, Inc. Announces Second Quarter Fiscal Year 2022 Earnings Conference Webcast | |
| 19.01. | Catalent Launches New Xpress Pharmaceutics Service to Expedite Development of Oral Drug.. | |
| 18.01. | CATALENT : Launches New Xpress Pharmaceutics™ Service to Expedite Development of Ora.. | |
| 11.01. | CATALENT : Increases Specialized Packaging Capabilities at its Philadelphia Facility to Su.. | |
| 10.01. | Catalent to Seek M&A | |
| 10.01. | TRANSCRIPT : Catalent, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-09.. | |
| 10.01. | CATALENT : Investor Presentation – J.P. Morgan Healthcare Conference | |
| 05.01. | AT&T, Walmart rise; PG&E, Catalent fall | |
| 05.01. | Catalent Promotes COO Alessandro Maselli to Chief Executive | |
| 05.01. | CATALENT : Announces Plan for Alessandro Maselli to Become New CEO Effective July 1, 2022 .. | |
| 05.01. | CATALENT, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Fina.. | |
| 05.01. | Catalent, Inc. Announces Executive Changes | |
| 05.01. | Catalent, Inc. Announces CEO Succession | |
| 05.01. | Catalent Announces Plan for Alessandro Maselli to Become New CEO Effective July 1, 2022 | |
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
